Catalysts for Ingenus Pharmaceuticals LLC
13 tracked
Dec 11, 2025
approval
CABERGOLINE — FDA approval
CABERGOLINE
→
Oct 23, 2025
approval
DESIPRAMINE HYDROCHLORIDE — FDA approval
DESIPRAMINE HYDROCHLORIDE
→
Oct 15, 2025
approval
CONJUGATED ESTROGENS (ESTROGENS, CONJUGATED) — FDA approval
Ingenus Pharmaceuticals LLC
→
Oct 15, 2025
approval
CONJUGATED ESTROGENS (ESTROGENS, CONJUGATED) — FDA approval
Ingenus Pharmaceuticals LLC
→
Sep 29, 2025
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
TIZANIDINE HYDROCHLORIDE
→
Jun 12, 2023
approval
DESIPRAMINE HYDROCHLORIDE — FDA approval
DESIPRAMINE HYDROCHLORIDE
→
May 27, 2022
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
TIZANIDINE HYDROCHLORIDE
→
Mar 16, 2021
approval
DESIPRAMINE HYDROCHLORIDE — FDA approval
DESIPRAMINE HYDROCHLORIDE
→
Dec 13, 2019
approval
CABERGOLINE — FDA approval
CABERGOLINE
→
Sep 30, 2019
approval
DESIPRAMINE HYDROCHLORIDE — FDA approval
DESIPRAMINE HYDROCHLORIDE
→
Mar 12, 2019
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
TIZANIDINE HYDROCHLORIDE
→
Aug 1, 2018
approval
CABERGOLINE — FDA approval
CABERGOLINE
→
Dec 26, 2017
approval
DESIPRAMINE HYDROCHLORIDE — FDA approval
DESIPRAMINE HYDROCHLORIDE
→